Formation of large amounts of toxic oxygen-derived free radicals in hypoxic and ischemic brain has been proposed as an important step in the sequence of events that links cerebral blood flow reduction to neuronal death (Demopoulos et al., 1980; Siesjo, 198 1; Raichle, 1983; Braughler and Hall, 1989; Hall and Braughler, 1989) . Free radical formation has been demonstrated both during the acute ischemic attack (Demopoulos et al., 1980) and when blood and oxygen eventually return to the brain upon reperfusion (McCord, 1985) . Certainly, free radical scavengers seem to be able to reduce anoxic or ischemic neuronal damage both in vitro and in vivo (Smith et al., 1980; Taylor et al., 1984 Taylor et al., , 1985 Itoh et al., 1986; Cao et al., 1988; Sasaki et al., 1988) .
Another research line that has been thoroughly and independently investigated in order to understand the cause of neuronal damage induced by hypoxic or ischemic states deals with the excitatory amino acids (EAA) aspartate (Asp) and glutamate (Glu), synaptically released transmitters which are endowed with neurotoxic effects (Rothman and Olney, 1986, 1987; Choi, 1988a ). An increased release of Glu and/or Asp has been observed both during anoxia in vitro (Bosley et al., 1983; Hauptman et al., 1984) and during cerebral ischemia in vivo (Benveniste et al., 1984; Erecinska et al., 1984; Hagberg et al., 1985; Globus et al., 1988) . Furthermore, EAA receptor antagonists have been shown to offer protection against anoxic neuronal death in vitro (Rothman, 1984; Clark and Rothman, 1987; Goldberg et al., 1987) or ischemic brain damage in viva (Simon et al., 1984; Gill et al., 1987; Andint et al., 1988; Kochhar et al., 1988) . Recently, a reduction in the number of EAA receptors following ischemia has also been reported (Westerberg et al., 1987; Leach et al., 1988) .
Our working hypothesis was that these 2 metabolic events, namely, free radical formation and EAA release, are mutually related and cooperate in the series of events that link brain anoxia or ischemia to neuronal death. For this purpose we developed an in vitro model of simulated ischemia, and we studied the EAA release from the hippocampus, a brain region particularly sensitive to hypoxic or ischemic insults (Smith et al., 1984) .
Materials and Methods
Materials. Allopurinol, corticosterone, indomethacin, kynurenic acid (KIN), n-mannitol, o-phthalaldehyde, and xanthine were purchased from Sigma Chemical Co. (St. Louis, MO). Catalase (65,000 U/mg protein), lactate dehydrogenase (LDH; 550 U/mg protein), superoxide dismutase (SOD, 5000 U/mg lyophilisate), and xanthine oxidase (XOD, lU/mg urotein) were from Boehrinaer Mannheim GmbH (FRG). Ar---~ I achidonic acid and prostaglandin synthase (PGS) were from Calbiochem Corporation (San Diego, CA). DJH-Asp (10-30 Ci/mmol) was from Amersham (Amity PG, Milan), ethylmercaptan from Fluka AG (Buchs, Switzerland), and 6,7,dinitroquinoxaline-2,3-dione (DNQX) from Tocris Neuramin (Buckhurst Hill, Essex, UK). All other reagents were from Merck (Darmstadt, FRG), analytical grade.
Preparation of rat hippocampalslices andin vitro experimental models. Male Wistar rats (Nossan strain, Milan), weighing 180-200 gm were used. After decapitation, their hippocampi were rapidly removed and plunged into ice-cold Krebs-bicarbonate buffer (in mM: NaCl, 122; KCl, 3.1; MgSO,, 1.2; KH, PO, , 0.4; CaCl, , 1.3; NaHCO, , 25; and glucose, 10) . Transverse slices (350 pm thick) were cut with a McIlwain tissue chopper from each hippocampus and then left to stand, dipped into Krebs-bicarbonate solution gassed with 95% 0,/5% CO, for 2 hr at room temperature in order to allow functional recovery. After this pe- "Hypoxia" was obtained by incubating rat hippocampal slices for 10 min in a medium bubbled with N, instead of O,, "hypoglycemia" by incubation in a glucose-free medium, and "ischemia" by a combination of these 2 conditions. a p < 0.0 1 vs control release. " p < 0.0 1 vs KCl-induced release.
riod, viability was electrophysiologically assessed in some of the slices according to Corradetti et al. (1983) , and they were then placed into test tubes (5 slices each) containing 650 ~1 of gassed solution at 32"C, with or without the drugs under study.
In order to iimulate ischemic or hypoxic injury to the brain, viable hippocampal slices were incubated in test tubes for 10 min in glucosefree Krebs-bicarbonate solution saturated with 95% N,/5% CO, ("ischemia"), while other slices were incubated with glucose-containing buffer bubbled with 95% N,/5% CO, ("hypoxia") or with glucose-free solution gassed with 95%0,/5% CO, ("hypoglycemia").
When the effects of enzymatically formed free radicals on hippocampal release were studied, the slices were incubated for 20 min at 32°C in Krebs-bicarbonate buffer gassed with 95% 0,/5% CO, and containing xanthine plus XOD or arachidonate plus PGS, which are excellent sources of superoxide anion (OF), hydrogen peroxide (H,O,), and hydroxyl radical (OH.) (Kellogg and Fridovich, 1977) .
In some experiments, a 50 mM KCI-containing buffer (with isomolar reduction of NaCl) was utilized, while in others CaCl, was omitted from the medium and replaced by 1 mM EGTA.
Studies on D-jH-Asp release. For this set of experiments, hippocampal slices were previously incubated for 45 min at 32°C in oxygenated buffer containing D-'H-Asp (final concentration, 50 nM), then washed for 30 min with fresh solution, and finally transferred into the test tubes (2 slices each) containing one of the different gassed solutions. The experimental reactions were carried out for 10 min and were then terminated by cooling the test tubes in an ice bath. The supematant was separated from the slices by gentle filtration on Whatman GF/C filters, and the tritium content of both the supematant and the solubilized slices, after the addition of an appropriate amount of scintillation fluid, was counted on a Packard (Tri Carb 1500) liquid scintillation analyzer. Labeled release was calculated as (cpm tritium present in the supematant)/(cpm tritium left in the slices) x 100, and statistical differences were evaluated by performing analysis of variance on overall data and modified t statistics (Wallenstein et al., 1980) on individual comparisons.
Studies on endogenous Asp and GIu release. Hippocampal slices were prepared as described, and 5 of them were kept in each test tube for 10 min at 32°C in the required experimental conditions. After cooling the test tubes in an ice bath, aliquots (500 ~1) of the supematant were removed and stored at -20°C for subsequent analysis. Slices were used for protein determination (Lowry et al., 195 1) . Endogenous Glu and Asp were measured by HPLC and fluorimetric detection after a precolumn derivatization procedure with o-phthalaldehyde and ethylmercaptan (Connick and Stone, 1988) . Aliquots (200 ~1) of each sample were rapidly mixed with 100 ~1 of the derivatizing solution before being injected in the HPLC apparatus. This reaction, which led to the formation of the I-alkyl-thio-2-alkyl substituted isoindole derivatives of the amino acids, proved to be stable for at least 60 min, giving identical results at different times of injection within this period. Injections of 100 ~1 were made into an HPLC apparatus, consisting of a Perkin-Elmer ISS-100 autosampler, 2 Perkin-Elmer Series 10 pumps, a Perkin-Elmer Series 20 LC controller, and a Perkin-Elmer LS3 fluorescence spectrometer with a wavelength of 334 nm and emission cut-off filter at 426 nm. Separation was performed on a PerkinElmer reversed-phase C,, column (15 cm x 2.6 mm, 5 pm particle size) fitted with a C,, "guard pak" precolumn (Waters). Solvent A was 65% methanol in water, and solvent B was 50 mM sodium acetate and 50 mM NaH,PO,. The gradient program started from 20% of solvent A at the moment of injection and reached 80% in 12 min. Asp and Glu derivatives were identified by their retention times relative to reference injections of standard Asp and Glu, and their concentrations were quantified by comparing sample and reference peak heights. This procedure gave results that were comparable to those obtained with a gas chromatography-mass spectrometer method previously described (Moroni et al., 198 1) .
Glu and Asp release were expressed as pmol/mg protein/20 min, and statistical analysis was carried out as indicated for radiolabeled release.
LDH activity assay. Nonspecific lysis of neuronal cells was studied by detecting the activity of LDH, a typical cytoplasmic enzyme, in the supematant of slices exposed for 10 min to the different described procedures, by means of a spectrophotometric assay (Vassault, 1983 almost doubled when slices were depolarized with 50 mM IQ upon depolarization, "hypoxic," "hypoglycemic," and "ischemic" slices displayed a significantly higher efflux of label (Table   1 ).
Table 1 also shows that endogenous Asp and Glu release were qualitatively affected in the same manner by the different experimental challenges, the only difference being the more pronounced enhancement of basal and stimulated control outflows. Basal Asp and Glu release were increased by lo-and 20-fold, respectively, under ischemic conditions, while hypoxia and hypoglycemia alone were ineffective. In control slices (presence of glucose and normal oxygenation), 50 mM KC1 induced a 7-fold potentiation of Asp output and a 15fold potentiation of that of Glu. Hypoxia and hypoglycemia alone were capable of increasing Asp and Glu release, but, as in the case of D-~H-As~, the ischemic challenge yielded greater effects (Table 1) . Caz+ dependence of basal, stimulated (50 mM KCl), "ischemit" (incubation for 10 min in glucose-and O,-free medium) and of stimulated "ischemic" release of n-'H-aspartate from rat hippocampal slices. n-'H-release is expressed as a percentage of control (see Table 1 for release values of different experimental conditions in the presence of Ca*+ the presence of Ca*+ in the medium, while the ischemia-induced increase of basal release was not at all affected by the absence of Ca2+ (Figs. 1, 2) . In order to ascertain whether nonspecific lysis of the cell could be the cause of the observed outflow of labeled or endogenous amino acids, the activity of LDH, a specific cytoplasmic enzyme, was measured in the supernatant of slices treated under the experimental conditions described above. When slices were incubated alone for 20 min at 37°C LDH activity in the incubation medium was 0.64 f 0.05 U/liter (n = 4). After 10 min of hypoxia, the release was 0.70 f 0.05, and in the presence of 0.5 mM xanthine plus 20 mu/ml XOD, it was 0.72 +-0.06 U/liter (not significant). The addition of Triton X-100 (0.1%) to the incubation medium for 15 min increased LDH activity in the supernatant to 65.1 f 0.5 U/liter.
Effects of free radical scavengers and enzyme inhibitors on &hernia-induced EAA release Table 2 shows that D-mannitol (1 mM), a hydroxyl radical scavenger, was able to reduce (by 64%) the ischemia-induced increase in tritium outflow from hippocampal slices preloaded with DJH-Asp, when added to the incubation medium. The 0, scavenger system formed by SOD (50 &ml) plus catalase (50 &ml) was almost equally potent in this reducing effect (63%). Indomethacin (50 MM) and corticosterone (50 PM), which are inhibitors, at different stages, of enzymatic free radical production, partially reduced this increase (by 43 and 51%, respectively). Table 2) . None of the free radical scavengers or inhibitors tested modified the release of labeled or endogenous Asp and Glu induced by 50 mM KC1 (data not shown).
Effects of xanthine plus XOD and of arachidonate plus PGS on EAA release When slices preloaded with D-'H-As~ were exposed to xanthine (0.5 mM) plus XOD (20 mu/ml) for 20 min, they released an increased amount of tritium (+50%, Fig. 3 ). This increase was further potentiated in the absence of Ca*+ in the medium. Allopurinol (10 PM), a specific inhibitor of XOD, was able to prevent almost completely (-70%) the xanthine plus XODinduced release, which was also significantly reduced by the radical scavengers o-mannitol (1 mM) and SOD (50 pg/ml) plus catalase (50 &ml) (by 56 and 20% respectively; Fig. 3 ). The xanthine plus XOD enzymatic reaction also led to a 2.5-fold Ca2+-independent increase of endogenous Asp output and to a 3.2-fold increase of that of endogenous Glu (Fig. 3) . This release was inhibited by 10 /IM allopurinol (77% reduction for Asp and 81% for Glu), by 1 mM D-mannitol (58 and 34% reductions, respectively), and by SOD plus catalase (68 and 58%, respectively).
Similarly, the output of endogenous Asp and that of Glu increased from 35.9 + 5.3 and 69.4 ? 14 pmol/mg protein, under basal conditions, to 61.4 + 9.3 and 157.5 * 18 pmol/ mg protein, respectively, when the slices were incubated for 10 min in the presence of 100 I.LM arachidonate and 500 mU PGS (n = 4, p < 0.01).
LDH activity was not modified in the supematant of slices exposed to these treatments.
Efects of EAA receptor antagonists on endogenous Glu and Asp release Table 3 shows that KYN (100-300 PM), a nonselective EAA receptor antagonist (Stone and Burton, 1988) and DNQX (lo-30 PM), a putative blocker of EAA receptors of the non-hr-methyl-D-aspartate type (Honor6 et al., 1988) , when added to the "ischemic" incubation medium, were able to reduce endogenous Asp and Glu release from hippocampal slices. On the other hand, neither the NMDA receptor antagonist D,L-2-amino-5-phosphonovaleric acid (AP5) nor the selective glycine antagonist 7-Cl-kynurenate (7-Cl-KYN) (Kemp et al., 1988) at fully active concentrations significantly reduced ischemia-induced EAA release. 
"Ischemia" was obtained by incubating hippocampal slices in a glucose-free and O,-substituted (with NJ medium for 10 min. Values are means + SEM of at least 5 experiments, all conducted in triplicate. See legend to Table 1 and Materials and Methods for experimental and statistical procedures. up < 0.05 vs ischemia alone. b p c 0.0 1 vs ischemia alone.
Discussion
The aim of our study was to clarify the relationship between 2 widely studied pathogenetic events linking hypoxic or ischemic brain damage to the death of neurons: production of free radicals (Siesjo, 198 1; Raichle, 1983; Braughler and Hall, 1989) and abnormal extracellular concentrations of EAA (Meldrum, 1985; Rothman and Olney, 1986; Choi, 1988a) . Our first step was to develop a satisfactory in vitro model of ischemia, in which EAA release could be detected. Similar models have been reported previously (Bosley et al., 1983; Hauptman et al., 1984; Drejer et al., 1985) . Initial results showed that slices from rat hippocampi, not exposed to depolarizing solutions, released large amounts of D-)H-Asp and of endogenous Asp and Glu only when incubated with a medium mimicking in vivo ischemic conditions (lack of both glucose and 0,). A much more pronounced outflow of EAA was observed when hypoxic, hypoglycemic, or ischemic conditions were tested in the presence of 50 mM KCl. However, we focused our attention on the nondepolarized ischemic approach because the simultaneous occurrence of both oxygen and glucose deprivation closely resembles what happens during stroke; because, in this case, the appearance of EAA in the medium was unaffected by the extracellular concentrations of Ca2+; and because it was not associated with possible nonspecific cellular lysis, since the activity of the cytoplasmic enzyme LDH was not increased in the incubation medium. In our "ischemic" model, this efflux of EAA could not be ascribed simply to the rise in extracellular K+ which has been shown during ischemia (Hansen, 1985) , since the addition of KC1 to the "ischemic" slices produced a further increase in EAA outflow, which was not lower than that induced by KC1 in control slices. Furthermore, the KCl-induced EAA output was CA*+-dependent, while the phenomenon we studied was not (see also Sanchez-Prieto and Gonzalez, 1988; Ikeda et al., 1989) .
The observation that the "ischemia"-induced appearance of EAA in the incubation medium could be significantly reduced by compounds such as D-mannitol, indomethacin, corticosterone, and the enzymes catalase and SOD, which have in common the ability to "scavenge" or reduce the formation of oxygen-derived free radicals, demonstrated that these active molecular species were involved in the elevation of EAA concentrations in the extracellular medium. A direct demonstration Figure 4 . Hypothetical vicious circle illustrating the possible mutual cooperation between free radical formation and EAA release in the pathogenesis of neuronal damage induced by hypoxia and ischemia. Toxic free radicals, formed following the reduction in blood flow or oxygen supply to the brain promote the release of EAA, which in turn may exert their toxic effects by interacting with specific receptors. Stimulation of EAA receptors increases intracellular CaZ+ concentrations, resulting in both neuronal damage and further production of free radicals (Choi, 1988b; Siesjo and Bengtsson, 1989) . This gives the possibility of starting another cycle. It is possible to interrupt this circle by using (I) free radical scavengers and enzyme inhibitors or (2) EAA receptor antagonists. See text for further discussion.
of this hypothesis was obtained by showing that the incubation of hippocampal slices with systems leading to free radical formation (xanthine plus XOD or arachidonate plus PGS) resulted in an increase of the release of both D-~H-As~ and endogenous Asp and Glu. The possibility that free radical formation may release intracellular active components has been previously reported (Ohmori et al., 1980; Mannaioni and Masini, 1988) . The formation of free radicals during hypoxic or ischemic states is widely accepted Hall and Braughler, 1989) . It has been proposed that they are formed mainly during the reperfusion of previously ischemic tissues, 
Means + SE of at least 4 experiments conducted in duplicate as picomol/mg protein110 min and percentages of the "ischemia"-induced release are given. See Table 1 and Materials and Methods for experimental and statistical procedures. L1 p < 0.01 vs ischemia alone.
by means of reactions involving XOD (McCord, 1985) , PGS (Rehncrona et al., 1982; Kontos and Wei, 1986) or mitochondrial ubisemiquinone (Turrens et al., 1985; Patole et al., 1986) . However, free radicals may also be formed during incomplete ischemia or even during complete ischemia or anoxia. In these cases, 0, brought in by collateral vessels (Flamm et al., 1978) , the "univalent leak" of 0, from mitochondria (Del Maestro, 1980) , and the possibility of free radical formation even when tissues contain only 5% of normal 0, levels (Demopoulos et al., Cao, W., J. M. Camey, A. Duchon, R. A. Floyd, and M. Chevion (1988) From these studies it is not possible to understand which might be the source of free radicals in our ischemic model. It is likely that those mechanisms which are operative during incomplete or complete ischemia are also important in our experimental conditions. In any case, our experiments utilizing an exogenous source of free radicals (xanthine plus XOD or arachidonic acid plus PGS) clearly demonstrate that they are indeed able to induce the outflow of EAA. Moreover, previous experiments from our group had shown that these enzymatic reactions were also able to release )H-noradrenaline from preloaded slices (Pellegrini-Giampietro et al., 1988) . Altogether, these data suggest that free radicals, formed either under simulated ischemic conditions or by enzymatic reaction, lead to a nonspecific 16akage of neurotransmitters.
It has been previously shown that EAA receptor agonists may promote enzymatic reactions leading to free radical production (Dumuis et al., 1988) and that excitotoxin-induced neuronal damage may be reduced by free radical scavengers (Dykens et al., 1987) . This led us to hypothesize the existence of a vicious circle, in which free radical formation and EAA release could affect each other in the generation and propagation of ischemic neuronal death (Fig. 4) . This proposed mechanism could account for the efficacy of free radical scavengers in preventing both EAA release (our data) and excitotoxin-mediated functional and morphological impairment (Lassmann et al., 1984; Baran et al., 1987; Dykens et al., 1987) (Fig. 4, point 1) . In support of the existence of such a vicious circle stand also the experiments shown in Table 3 showing that EAA receptor antagonists such as KYN and DNQX reduced the "ischemia"-induced EAA output (Fig. 4, point 2 ). In the model here described, the EAA receptors involved appear to be ofnon-NMDA type, since AP5, a typical NMDA antagonist, or 7-Cl-KYN, a compound able to antagonize the strychnine-insensitive glytine site associated to the NMDA receptor ion channel complex, failed to reduce the EAA release in ischemic conditions.
